Exact Sciences (EXAS) Tops Q1 EPS by 9c, Offers FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Exact Sciences (EXAS) PT Raised to $35 at Jefferies
April 28, 2017 10:40 AM EDTJefferies raised its price target on Exact Sciences (NASDAQ: EXAS) to $35.00 (from $25.00) while maintaining a Buy rating. Test volumes surged to ~100K units compared to Jefferies' ~88K expectations, reflecting a sharp acceleration from its run-rate over the past year.
EXAS raised its 2017... More
Exact Sciences (EXAS) PT Raised to $40 at Cowen; Guides Still Looks 'Very Conservative'
April 27, 2017 3:35 PM EDTCowen raised its price target on Exact Sciences (NASDAQ: EXAS) to $40.00 (from $30.00) while maintaining a Outperform rating following a solid start to the year.
Analyst Doug Schenkel noted revenue, new practice additions, and total orders were well ahead of expectations. In... More
